|
Volumn 32, Issue 8, 2008, Pages
|
Can big pharma produce the next generation of medicines?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOTECHNOLOGY;
COST BENEFIT ANALYSIS;
DRUG COST;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG QUALITY;
DRUG RESEARCH;
HEALTH CARE COST;
PATENT;
PROSPECTIVE PRICING;
SHORT SURVEY;
|
EID: 49449089300
PISSN: 15432521
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (3)
|
References (0)
|